SCHEMBL12187157

SCHEMBL12187157

CO[C@H]1OC[C@](C)(O)C[C@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12286847 0.74 — —
SCHEMBL18696906 0.72 — —
SCHEMBL20643267 0.69 — —
SCHEMBL15459175 0.68 — —
SCHEMBL13599581 0.68 — —
SCHEMBL13074380 0.68 — —
SCHEMBL7151533 0.65 — —
SCHEMBL6914298 0.64 LMNA (0.45) —
SCHEMBL15462569 0.64 LMNA (0.45) —
SCHEMBL2441587 0.64 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011143497-A1 AMINOGLYCOSIDE DERIVATIVES REMPEX PHARMACEUTICALS, INC. (US) 2011-11-17 — — WO disclosed
WO-2010132839-A2 AMINOGLYCOSIDE DOSING REGIMENS ACHAOGEN, INC. (US) 2010-11-18 — — WO disclosed
Send feedback